pharma.markets

pharma.markets

  • HOME
  • Imprint

Month: January 2022

New imaging method reveals causes of cerebral oedema

31/01/2022 MaP 0

Neurobiology: Publication in the Journal for Neuroscience Cerebral oedema is a dangerous complication in many brain-related conditions such as strokes. Researchers at the Institute of […]

FDA approves Roche’s Vabysmo, the first bispecific antibody for the eye, to treat two leading causes of vision loss

31/01/2022 MaP 0

Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME) Vabysmo is the […]

Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccine-induced Antibodies Ability to Neutralize SARS-CoV-2 Omicron Variant

24/01/2022 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies demonstrating that three doses of […]

U.S. EPA and World Health Organization Partner to Protect Public Health

20/01/2022 MaP 0

Agreement recognizes the increased environmental and public health risks from the warming global climate and prioritizes environmental justice This week, the U.S. Environmental Protection Agency […]

Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022

20/01/2022 MaP 0

Surpasses 900 trials across 65 countries, expands leadership team and product offerings, and posts another year of 30% growth, all while maintaining an exceptional performance […]

The Zika Virus´s Immune Escape Strategy

18/01/2022 MaP 0

– Important Insights for the Development of Antiviral Therapies A research team led by the Paul-Ehrlich-Institut examined the interaction between the Zika virus and the […]

WHO Virtual Press Conference on COVID-19 and other global health issues, 18 January

18/01/2022 MaP 0

WHO Director-General’s opening remarks at the media briefing on COVID-19 — 18 January 2022 The volcanic eruption near Tonga and subsequent tsunami requires an urgent […]

COVAX delivers its 1 billionth COVID-19 vaccine dose – with video

16/01/2022 MaP 0

On 15 January 2021, a shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX. Together with our partners, COVAX […]

WHO Interim statement on COVID-19 vaccines

11/01/2022 MaP 0

Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine […]

BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants

11/01/2022 MaP 0

Early Warning System combines Spike protein structural modeling with artificial intelligence (AI) to detect and monitor high-risk SARS-CoV-2 variants, identifying >90% of WHO-designated variants on […]

Immune Biosolutions reports that its lead immunotherapy product IBIO123 neutralizes 100% of the SARS-CoV-2 variants of concern (VOCs), including Omicron

10/01/2022 MaP 0

Immune Biosolutions Inc., a clinical-stage company, is pleased to announce that its leading biological drug candidate maintains a potent activity in neutralization assays. Recent results […]

BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies

10/01/2022 MaP 0

Collaboration leverages BioNTech’s proprietary multimodal immunotherapy expertise with Crescendo’s proprietary Humabody® VH platform to develop precision immunotherapies, including mRNA-based antibodies and engineered cell therapies against […]

For the first time in medical history, an autonomous drone helps save the life of a cardiac arrest patient

06/01/2022 MaP 0

For the first time in medical history, a drone has played a crucial part in saving a life during a sudden cardiac arrest. The world […]

Adare Pharma Solutions Announces Appointment of Tom Sellig as Chief Executive Officer

06/01/2022 MaP 0

Sellig Will Drive Enhanced Customer Service and Go-To-Market Strategy  Adare Pharma Solutions (“Adare”), a global, technology-driven contract development and manufacturing organization (CDMO), today announced the […]

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

06/01/2022 MaP 0

Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted […]

Posts navigation

1 2 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • Cosmetics
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • Innovation
  • Mental Health
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Therapy
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®
  • Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer
  • BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

Archive

  • February 2023 (3)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

    04/02/2023 0
  • Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer

    04/02/2023 0
  • BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

    02/02/2023 0
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

    27/01/2023 0
  • Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

    26/01/2023 0
Archives
  • February 2023 (3)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 economy elpais.com emergency eu europe european fda food global guarantee health hygiene investment links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support test vaccine who

Copyright © 2023 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner